Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents-Reference-Cited by-同舟云学术

Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents

Published:2017-06-19 Issue:4 Volume:121 Page:316-324
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Nuntamool Nopphadol¹²³,Ngamsamut Nattawat⁴,Vanwong Natchaya¹²,Puangpetch Apichaya¹²,Chamnanphon Monpat¹²,Hongkaew Yaowaluck¹²,Limsila Penkhae⁴,Suthisisang Chuthamanee⁵,Wilffert Bob⁶⁷,Sukasem Chonlaphat¹²

Affiliation:

1. Division of Pharmacogenomics and Personalized Medicine; Department of Pathology; Faculty of Medicine, Ramathibodi Hospital; Mahidol University; Bangkok Thailand

2. Laboratory for Pharmacogenomics; Somdech Phra Debaratana Medical Center (SDMC); Ramathibodi Hospital; Bangkok Thailand

3. Molecular Medicine; Faculty of Science; Mahidol University; Bangkok Thailand

4. Department of Mental Health Services; Yuwaprasart Waithayopathum Child and Adolescent Psychiatric Hospital; Ministry of Public Health; Samut Prakarn Thailand

5. Department of Pharmacology; Faculty of Pharmacy; Mahidol University; Bangkok Thailand

6. Unit of PharmacoTherapy, -Epidemiology & -Economics; Department of Pharmacy; University of Groningen; Groningen The Netherlands

7. Department of Clinical Pharmacy and Pharmacology; University of Groningen; University Medical Center Groningen; Groningen The Netherlands

Funder

Pharmacogenomics for Autistic Child Project, Khoon Poom Foundation, The Project in Her Royal Highness Princess Ubonratana Rajakanya Siriwatana Bhanawadee

Office of National Research Council of Thailand

Faculty of Medicine Ramathibodi Hospital

Mahidol University

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12803/fullpdf

Reference39 articles.

1. Psychopharmacological interventions in autism spectrum disorder;Politte;Harv Rev Psychiatry,2014

2. MDR1 (ABCB1) polymorphisms: functional effects and clinical implications;Brambila-Tapia;Rev Invest Clin,2013

3. An open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder;Kent;J Child Adolesc Psychopharmacol,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism;European Journal of Clinical Pharmacology;2024-02-29

2. Exploratory focused pharmacogenetic testing reveals novel markers associated with risperidone pharmacokinetics in Saudi children with autism;Frontiers in Pharmacology;2024-02-05

3. Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications;Frontiers in Pharmacology;2024-02-05

4. Association study between D2 receptor A-241G, rs1799978 genetic variation and olanzapine efficacy in Iraqi schizophrenic patients;Pharmacia;2024-01-29

5. The Frequency of CYP2D6 and CYP3A4/5 Genotypes and The Impact of Their Allele Translation and Phenoconversion-Predicted Enzyme Activity on Risperidone Pharmacokinetics in Saudi Children with Autism;Biochemical Genetics;2023-12-02